Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
about
Mesenchymal stem cells avoid allogeneic rejectionModulation of T-cell activation by malignant melanoma initiating cellsVEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growthThe nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.Immunotherapy for head and neck squamous cell carcinomaChallenges in Antibody Development against Tn and Sialyl-Tn AntigensImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsVal-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumorsEvolutionary foundations for cancer biologyT-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.The therapeutic promise of the cancer stem cell concept.Immune-based therapeutics for pediatric cancer.Novel targeted therapeutics for metastatic castration-resistant prostate cancer.Immunotherapy of childhood cancer: from biologic understanding to clinical application.Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.Identification and targeting of cancer stem cells.Could cancer initiate from bone marrow progenitors?Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.Tumor antigen cross-presentation and the dendritic cell: where it all begins?Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.Immunologic targeting of FOXP3 in inflammatory breast cancer cells.Pancreatic ductal adenocarcinoma: long-term survival does not equal cureIntratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity.Emerging molecular targets for the treatment of pre-eclampsia.Prolonged overall survival in gastric cancer patients after adoptive immunotherapyAnalysis of the involvement of cytokines in allergy and breast cancer association.Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysisIL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumorsImmunotherapy in Metastatic Renal Cell Carcinoma: A Comprehensive Review.Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse.The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.The messenger and the message: gp96 (GRP94)-peptide interactions in cellular immunityIrradiation of donor mononuclear cells for treatment of chemorefractory metastatic solid cancers: a community-based immune transplant pilot studyDevelopment of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer.Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?Notch: a unique therapeutic target for immunomodulation.Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.
P2860
Q21245658-EB1E6B11-7511-4A93-8674-E52056E8654DQ24595394-06832B76-FA62-41A9-86B8-CF9037D1589EQ24606018-F1D73C11-2D38-4D9F-A0F4-08F36BCEC78BQ24815528-C24DBF06-2AB4-405E-9307-C792EA51B2E3Q26739850-203AEB8C-CF7C-4138-8A40-A6D007F1009DQ26798183-7C682BBC-CA79-4145-BB62-961715D3ACA1Q26798402-CA41CF7A-3BA2-43E7-B78D-FA917F27919AQ26865532-92FE2DF3-6650-4F34-8913-B9CE85BCDCBCQ28395507-0E8CAC2B-21C5-41AC-A8E0-4B28303455A0Q28709090-0252EEC5-7912-4A5D-BD22-A48DACD4317FQ31032531-0F3B947B-11FF-4402-A471-AA9B56562FCDQ33559711-5B9E34F4-61C1-4B79-B434-0140ABCD05FCQ33604121-1DD7EB09-008B-418F-985D-A7595E3B58D2Q33642278-32DDD2E2-994C-4307-AEE2-E21143482D3EQ33752982-64A48E00-1F02-47FD-9896-FBAB9CE9C2FCQ33890619-A23B715F-B9F9-4201-80DF-87677BD1A00CQ33895262-EAEB1164-7082-4D5B-89C0-B68CE549FD50Q33921460-B4AAF20C-FD76-4A4B-9232-71DB44494BCDQ34082358-982B400E-2B6D-4EC7-967C-556DA4BD6044Q34205181-D806D8C4-11F9-4F53-8343-9A95758B67B9Q34210664-1A94C58E-1DE6-4B47-B1B1-C04453DDE523Q34439167-F57E8DE5-DE6E-4993-9FAB-48C1D0B5856DQ34558393-A407FE10-57BA-4CC7-B641-32D21514FB99Q34639984-F5A3D854-5457-4188-9537-0AE08EC78F64Q34654430-519E7AEB-2DBB-4DB4-8954-2E12E3048EBAQ35050406-E4F3405F-B2CA-40B4-93CA-9AA5D3566DB4Q35152386-A5537A3F-583C-4E77-8115-FF6B9C0DCD6BQ35165566-BA2126C5-4CC0-4B1D-B6A3-5975C3589DCCQ35173555-F66AC571-B50D-44A2-BFA1-4E42AF442BF9Q35578622-B52D4D72-BA00-43C0-B682-8565865663CCQ35673240-8BE52E4F-1F61-448F-89BE-8F6EB275D603Q35802508-2AA3EBC7-E1D8-411E-BB72-F6D842C60510Q35828638-9ACF4C44-7E9A-4856-B1F3-65173025CF6EQ35884237-DC68D9B7-0457-4FE7-BF21-A37B9A2AEDD7Q36000449-394BF546-64A8-4DFF-AC51-845D7D5983DFQ36089567-B15401EE-481A-4C00-92FA-3C39564C5731Q36140389-DB6961F7-92B1-4E36-8A4F-1A1428D6BE23Q36150417-68C73800-23F6-475F-9AC4-B040345EECA5Q36150879-2569AE93-44BC-4306-891E-CFF5340E793DQ36190047-727844D7-401D-45A1-8F63-D2CFF3B46C97
P2860
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@ast
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@en
type
label
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@ast
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@en
prefLabel
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@ast
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@en
P356
P1476
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
@en
P2093
Markus Y Mapara
Megan Sykes
P304
P356
10.1200/JCO.2004.10.041
P407
P577
2004-03-01T00:00:00Z